Defining the CMC / Clinical Relationship for Allogeneic Cell Therapies

CMC is the connection between the drug used in clinical studies and the drug that is marketed commercially and made available to consumers. During this segment, Nguyen and Wagner define why the relationship between CMC and Clinical is so critical, and they also explain what a mutually beneficial partnership between CMC and Clinical looks like. They share how the Regulatory impacts CMC and Clinical, and the ways in which we need to improve the CMC/Clinical relationship in order to bring more allogeneic therapies to market.